PATRICK O'CONNELL

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NOVI, MI NPI 1548899016

General Payments — all program years on this page

$1,168.87

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $888.67 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $888.6738

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $86.921
2022 $145.933
2023 $47.352
2024 $888.6738

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078052730 Janssen Pharmaceuticals, Inc $3.13 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052754 Janssen Pharmaceuticals, Inc $34.85 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052760 Janssen Pharmaceuticals, Inc $36.59 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052770 Janssen Pharmaceuticals, Inc $3.53 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052772 Janssen Pharmaceuticals, Inc $3.36 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052778 Janssen Pharmaceuticals, Inc $31.38 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052792 Janssen Pharmaceuticals, Inc $28.07 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052810 Janssen Pharmaceuticals, Inc $4.12 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101338967 E.R. Squibb & Sons, L.L.C. $24.61 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105140838 ABBVIE INC. $25.00 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105140840 ABBVIE INC. $15.17 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105140842 ABBVIE INC. $25.35 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105140844 ABBVIE INC. $24.34 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118953210 Otsuka America Pharmaceutical, Inc. $26.46 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118953212 Otsuka America Pharmaceutical, Inc. $22.68 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118953214 Otsuka America Pharmaceutical, Inc. $21.20 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118953216 Otsuka America Pharmaceutical, Inc. $20.08 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120565003 Alkermes, Inc. $16.60 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120565005 Alkermes, Inc. $22.77 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137645184 Takeda Pharmaceuticals U.S.A., Inc. $24.31 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137645186 Takeda Pharmaceuticals U.S.A., Inc. $20.46 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137645188 Takeda Pharmaceuticals U.S.A., Inc. $13.85 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288796 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $106.15 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288800 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.43 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288804 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.50 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288807 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.70 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288811 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.61 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288814 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.77 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288818 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.84 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288822 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.49 12/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145951807 Lundbeck LLC $16.15 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145951809 Lundbeck LLC $23.40 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145951811 Lundbeck LLC $22.78 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145951813 Lundbeck LLC $23.22 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148310072 Axsome Therapeutics, Inc. $26.77 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148310074 Axsome Therapeutics, Inc. $34.64 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150857554 Neurocrine Biosciences, Inc. $20.36 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151602493 Teva Pharmaceuticals USA, Inc. $22.95 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.